NCT03496610View on ClinicalTrials.gov

Surgeon Infiltration QL Block Comparison

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

February 23, 2023

Study Completion Date

February 23, 2023

Conditions
Quadratus Lumborum BlockSurgical Wound Infiltration
Interventions
DRUG

Liposomal Bupivicaine

Patient will receive liposomal bupivicaine mixed with non-liposomal bupivicaine directly to wound

PROCEDURE

QL Block

Patient will receive ultrasound guided QL Block

Trial Locations (1)

27705

Duke University, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER